- Home
- SLDP vs COLL Comparison
SLDP vs COLL Comparison
Compare SLDP & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDP
- COLL
- Stock Information
- Founded
- SLDP 2011
- COLL 2002
- Country
- SLDP United States
- COLL United States
- Employees
- SLDP N/A
- COLL N/A
- Industry
- SLDP Electrical Products
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- SLDP Energy
- COLL Health Care
- Exchange
- SLDP Nasdaq
- COLL Nasdaq
- Market Cap
- SLDP 1.3B
- COLL 1.1B
- IPO Year
- SLDP N/A
- COLL 2015
- Fundamental
- Price
- SLDP $6.61
- COLL $47.22
- Analyst Decision
- SLDP Strong Buy
- COLL Strong Buy
- Analyst Count
- SLDP 1
- COLL 5
- Target Price
- SLDP $7.00
- COLL $45.40
- AVG Volume (30 Days)
- SLDP 17.0M
- COLL 479.0K
- Earning Date
- SLDP 11-04-2025
- COLL 11-06-2025
- Dividend Yield
- SLDP N/A
- COLL N/A
- EPS Growth
- SLDP N/A
- COLL N/A
- EPS
- SLDP N/A
- COLL 1.63
- Revenue
- SLDP $19,802,000.00
- COLL $757,067,000.00
- Revenue This Year
- SLDP $27.38
- COLL $21.41
- Revenue Next Year
- SLDP $37.97
- COLL $3.28
- P/E Ratio
- SLDP N/A
- COLL $29.13
- Revenue Growth
- SLDP 9.85
- COLL 26.34
- 52 Week Low
- SLDP $0.68
- COLL $23.23
- 52 Week High
- SLDP $8.86
- COLL $47.35
- Technical
- Relative Strength Index (RSI)
- SLDP 53.53
- COLL 86.68
- Support Level
- SLDP $6.17
- COLL $35.26
- Resistance Level
- SLDP $8.02
- COLL $36.58
- Average True Range (ATR)
- SLDP 0.85
- COLL 1.48
- MACD
- SLDP 0.02
- COLL 1.26
- Stochastic Oscillator
- SLDP 40.05
- COLL 98.75
About SLDP Solid Power Inc.
Solid Power Inc is engaged in solid-state battery technology and manufacturing processes. Its core technology is a sulfide-based solid electrolyte material, which replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells. Its commercialization plan is to manufacture and sell electrolytes to Tier 1 battery manufacturers and automotive original equipment manufacturers (OEMs) that choose to produce its battery cells.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.